Delta DNA Inc. hopes to develop a kit to recover fetal DNA in maternal blood. By recovering fetal DNA, the fetus’ genetic issues, if any, can be detected more quickly and more reliably than with an invasive method such as amniocentesis. La Cité supported the business through the proof-of-concept phase of the project and contributed to recruiting pregnant women. The business developed a blood collection and conservation device that must be validated. The project’s main challenge is to find ways to stabilize and efficiently recover the fetal DNA that is present in minuscule quantities in the mother’s blood.